<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">Nucleic Acids Research</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16914419</article-id><article-id pub-id-type="pmc">PMC1557811</article-id><article-id pub-id-type="doi">10.1093/nar/gkl529</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genomics</subject></subj-group></article-categories><title-group><article-title>Gene function correlates with potential for G4 DNA formation in the human genome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eddy</surname><given-names>Johanna</given-names></name><xref rid="au1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Maizels</surname><given-names>Nancy</given-names></name><xref rid="au1" ref-type="aff">1</xref><xref rid="au2" ref-type="aff">2</xref><xref rid="au3" ref-type="aff">3</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="au1"><sup>1</sup><institution>Molecular and Cellular Biology Graduate Program, University of Washington School of Medicine</institution><addr-line>1959 NE Pacific Street, Seattle, WA 98195-7650, USA</addr-line></aff><aff id="au2"><sup>2</sup><institution>Department of Immunology, University of Washington School of Medicine</institution><addr-line>1959 NE Pacific Street, Seattle, WA 98195-7650, USA</addr-line></aff><aff id="au3"><sup>3</sup><institution>Department of Biochemistry, University of Washington School of Medicine</institution><addr-line>1959 NE Pacific Street, Seattle, WA 98195-7650, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><sup>*</sup>To whom correspondence should be addressed. Tel: +1 206 221 6876; Fax: +1 206 221 6781; Email: <email>maizels@u.washington.edu</email></corresp></author-notes><!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="ppub"><year>2006</year></pub-date><pub-date pub-type="epub"><day>10</day><month>8</month><year>2006</year></pub-date><volume>34</volume><issue>14</issue><fpage>3887</fpage><lpage>3896</lpage><history><date date-type="received"><day>13</day><month>6</month><year>2006</year></date><date date-type="rev-recd"><day>09</day><month>7</month><year>2006</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2006</year></date></history><copyright-statement>&#x000a9; 2006 The Author(s).</copyright-statement><copyright-year>2006</copyright-year><license license-type="openaccess"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"/>) which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><p>G-rich genomic regions can form G4 DNA upon transcription or replication. We have quantified the potential for G4 DNA formation (G4P) of the 16&#x02009;654 genes in the human RefSeq database, and then correlated gene function with G4P. We have found that very low and very high G4P correlates with specific functional classes of genes. Notably, tumor suppressor genes have very low G4P and proto-oncogenes have very high G4P. G4P of these genes is evenly distributed between exons and introns, and it does not reflect enrichment for CpG islands or local chromosomal environment. These results show that genomic structure undergoes selection based on gene function. Selection based on G4P could promote genomic stability (or instability) of specific classes of genes; or reflect mechanisms for global regulation of gene expression.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>Eukaryotic genomes contain characteristically G-rich regions, including single-copy genes; the rDNA; and repetitive sequences, such as the telomeres and the immunoglobulin heavy chain switch (S) regions of higher vertebrates. G-rich nucleic acids have the potential to form G-quadruplex or &#x02018;G4 DNA&#x02019;, a structure in which intra- or inter-strand interactions are stabilized by G-quartets, planar arrays of four guanines, paired by Hoogsteen bonding (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b2">2</xref>). G-quartets can stabilize a remarkable diversity of structures, in which the lengths and positions of the G-runs and the &#x02018;loops&#x02019; separating them both contribute to overall topology (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b4">4</xref>). In the human genome, the number of distinct sites with potential to form G4 DNA is estimated at more than 300&#x02009;000, and specific loop sequences are prominent at some of these sites (<xref ref-type="bibr" rid="b5">5</xref>,<xref ref-type="bibr" rid="b6">6</xref>).</p><p>Key cellular processes are identified with repetitive G-rich chromosomal regions, where regulated formation of G4 DNA may contribute to biological function. At the G-rich telomere tails, the presence of G4 DNA inhibits extension by telomerase, and proteins that bind specifically to telomeric sequences regulate the formation and resolution of G4 DNA (<xref ref-type="bibr" rid="b7">7</xref>&#x02013;<xref ref-type="bibr" rid="b15">15</xref>). The G-rich immunoglobulin switch regions are sites of recombination that is critical to B-cell development and the immune response, and regulated transcription of the switch regions induces the formation of DNA structures targeted by factors essential to class switch recombination (<xref ref-type="bibr" rid="b16">16</xref>,<xref ref-type="bibr" rid="b17">17</xref>).</p><p>G-rich regions can also be sites of unprogrammed genomic instability. Many B-cell lymphomas carry a translocation of the <italic>MYC</italic> proto-oncogene to the immunoglobulin heavy chain switch region (<xref ref-type="bibr" rid="b18">18</xref>), and the common translocation breakpoints map to G-rich regions of <italic>MYC</italic> that form structures similar to those formed by transcribed G-rich switch regions (<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b20">20</xref>). Some of the most unstable human minisatellites are G-rich sequences predicted to form G4 DNA (<xref ref-type="bibr" rid="b21">21</xref>); and G4 DNA formation <italic>in vitro</italic> has been directly confirmed for two G-rich VNTRs, D4S43, and the insulin-linked hypervariable repeat (<xref ref-type="bibr" rid="b22">22</xref>). Reporter constructs carrying interstitial telomeric repeats display high levels of instability (<xref ref-type="bibr" rid="b23">23</xref>), which may be analogous to the instability of G-rich VNTRs.</p><p>Specialized mechanisms may regulate the expression of G-rich genes at the levels of transcription, RNA processing and translation. Cotranscriptional RNA:DNA hybrid formation occurs readily within G-rich regions (<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b24">24</xref>,<xref ref-type="bibr" rid="b25">25</xref>). Factors associated with RNA processing pathways, including THO/TREX and ASF/SF2, normally prevent cotranscriptional RNA:DNA hybrid formation, and promote gene expression; and genomic instability ensues in their absence (<xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b27">27</xref>). Factors involved in translational regulation may target RNA transcripts that contain G-quartets (<xref ref-type="bibr" rid="b28">28</xref>,<xref ref-type="bibr" rid="b29">29</xref>). Regions with the potential to form G4 DNA have been identified in the promoters of several proto-oncogenes, including c-<italic>MYC</italic>, <italic>VEGF</italic>, c-<italic>KIT</italic> and <italic>BCL2</italic> (<xref ref-type="bibr" rid="b30">30</xref>&#x02013;<xref ref-type="bibr" rid="b33">33</xref>). This has led to suggestions that formation or resolution of specific quadruplex structures may contribute to the regulation of gene expression, and prompted the design of therapeutics targeted to these structures, but the biological specificity of such compounds is yet to be established rigorously (<xref ref-type="bibr" rid="b34">34</xref>&#x02013;<xref ref-type="bibr" rid="b39">39</xref>).</p><p>Conserved and ubiquitous repair factors recognize G4 DNA, including the human RecQ family helicases BLM and WRN (<xref ref-type="bibr" rid="b40">40</xref>,<xref ref-type="bibr" rid="b41">41</xref>); the <italic>Saccharomyces cerevisiae</italic> RecQ family helicase Sgs1 (<xref ref-type="bibr" rid="b42">42</xref>); and the mismatch repair factor MutS&#x003b1;, a heterodimer of MSH2/MSH6 (<xref ref-type="bibr" rid="b16">16</xref>). RecQ family helicases maintain G-rich regions during replication. Sgs1 is required for nucleolar stability and replication of the G-rich rDNA (<xref ref-type="bibr" rid="b43">43</xref>,<xref ref-type="bibr" rid="b44">44</xref>); and in the absence of WRN helicase, telomeric sequence is lost due to impaired replication of the G-rich strand (<xref ref-type="bibr" rid="b45">45</xref>). The mismatch repair factor, MutS&#x003b1;, may cooperate with BLM helicase to promote the resolution of G4 DNA during replication (<xref ref-type="bibr" rid="b46">46</xref>). In immunoglobulin switch recombination, MutS&#x003b1; recognizes G4 DNA formed during transcription of the G-rich switch regions to promote their synapsis and recombination (<xref ref-type="bibr" rid="b16">16</xref>).</p><p>Genomic regions with potential to form G4 DNA have been enumerated (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b5">5</xref>), but they have not been correlated with specific gene functions. The link between potential for G4 DNA formation and genomic instability suggests that the identification of human genes with relatively high or low potential to form G4 DNA might provide insights into the evolution of genomic structure, or identify mechanisms that could account for genomic instability in human malignancies. The possibility that G-richness can contribute to shared regulation suggests that genes with similar or related functions may share features of genomic structure. We therefore set out to determine the prevalence of G-rich sequences capable of forming G4 DNA among human genes, and to determine if particular functional classes of genes might be characterized by the presence or absence of G-rich regions.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>G4P Calculator software</title><p>We developed a software program, &#x02018;G4P Calculator&#x02019;, which computes G4 DNA potential based on the density of runs of guanines in a sequence. The program evaluates runs of guanines in a sliding window and calculates the percentage of windows searched that meet the specified criteria. The criteria used are as follows: G-run length, &#x02265;3; number of G-runs per window, &#x02265;4; window length, 100 nt; and sliding interval length, 20 nt. The requirement for four or more runs of three or more guanines is based on studies of oligonucleotide folding [reviewed in (2)]. The 100 nt window size facilitates rapid analysis and is easily reduced (or enlarged) for rescan of specific genes of interest. The 20 nt sliding interval length is set such that sequences with the potential to form more than a single G4 DNA structure make correspondingly higher contributions to the total G4P. The last four windows analyzed are processed as windows of progressively smaller size (80, 60, 40 and 20 nt), and this does not affect the results as gene length is much larger than window size. Each DNA strand is evaluated independently. G4P is scored as a percentage, making it independent of sequence length. These criteria are similar to those used by others (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b5">5</xref>), and although not absolute, provide a means to compare G4P between different sequences. The software is written in C# to run on the Microsoft Windows XP operating system. The program and instructions are available on our laboratory website (<ext-link ext-link-type="uri" xlink:href="http://depts.washington.edu/maizels9/"/>). The source code is available upon request.</p></sec><sec><title>Sequence and GO data</title><p>Sequence data for the human RefSeq genes (NCBI 35 assembly) and associated GO terms were downloaded from the Ensembl database v.32 using BioMart (<xref ref-type="bibr" rid="b47">47</xref>) on 4/9/05. Additional Gene Ontology (GO) data were obtained from the GO website (<ext-link ext-link-type="uri" xlink:href="www.geneontology.org"/>) on 3/5/06. Flanking sequence data were downloaded from Ensembl v.34 on 14/10/05. The cDNA sequences were downloaded from the Ensembl v.37 on 19/3/06. For genes with multiple transcript variants, the first listed variant for each gene was evaluated to assess G4P of the cDNA. The median G4 DNA potential was calculated from 16 654 RefSeq genes. Since each gene may have several GO classifications, a total of 77 968 GO term assignments were sorted above or below the median corresponding to 50.5% or 49.5% of the total. The 4524 RefSeq genes that have no GO classification (27% of the total) are equally distributed below and above the median.</p></sec><sec><title>Flanking sequence analysis</title><p>Analysis of &#x00394;G4P included only genes for which both gene and flanking sequence were complete. Excluded from that analysis were 101 genes for which sequence determination was incomplete (more than four unidentified consecutive bases). The excluded genes are identified in Supplementary Table 1; none of the excluded genes was a known proto-oncogene or a tumor suppressor gene.</p></sec><sec><title>Statistical analysis</title><p>The Wilcoxon rank sum test was applied by using the statistics program R 2.2.1 (Wilcoxon test parameters: alternative = &#x02018;two-sided&#x02019;, paired = FALSE). The linear regression, single-factor ANOVA, and standard error analyses were performed using Microsoft Office Excel 2003. Owing to the skewed distribution of G4P, data were subjected to a natural log transformation before linear regression analysis. Genes with G4P = 0 were therefore not included. This resulted in the exclusion of 1152 genes from the correlation between DNA strands (<xref ref-type="fig" rid="fig1">Figure 1B</xref>); and of 905 genes from the analysis of G4P versus GC content (Figure 3A).</p></sec><sec><title>CpG islands</title><p>The NewCpGReport software (<xref ref-type="bibr" rid="b48">48</xref>) was accessed and run from the website <ext-link ext-link-type="uri" xlink:href="http://csc-fserve.hh.med.ic.ac.uk/emboss/newcpgreport.html"/>. The tumor suppressor and proto-oncogene sequences were processed using the program's default settings: window size = 100; shift increment = 1; minimum length = 200; minimum observed/expected = 0.6; and minimum percent = 50.</p></sec></sec><sec><title>RESULTS</title><sec><title>G4 DNA formation potential of human genes</title><p>To score potential for G4 DNA formation, we developed software that analyzes overlapping windows of sequence, and scores each window that contains four or more runs of three or more guanines as a &#x02018;hit&#x02019;, then quantifies G4 DNA formation potential (G4P) as the percentage of hits in the total number of windows searched. We used this program, &#x02018;G4P Calculator&#x02019;, to evaluate the G4P of the entire transcribed sequence (exons and introns) of 16 654 human Reference Sequence (RefSeq) genes. Nontemplate and template strands were analyzed separately, to distinguish contributions of transcription-induced structure formation, which affects only the nontemplate strand; and replication-induced structure formation, which affects both strands. G4P of the nontemplate strand ranged from 0 to 79%, with a median of 5.0% and an average of 9.1% (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and Supplementary Table 1). Linear regression analysis (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) showed that G4P of the nontemplate and template strands is positively correlated (<italic>R</italic><sup>2</sup> = 0.73), with a slope of less than unity (0.83). Thus, for most genes, there is a slightly lower potential for the formation of transcription-induced structures than replication-induced structures; although potential for the formation of structures on either strand is closely correlated.</p></sec><sec><title>Gene function corresponds with G4P</title><p>The skewed distribution of G4P over the RefSeq genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) suggests that most genes cannot readily form G4 DNA structures, but that some genes may be highly susceptible. To identify functional classes of genes with high and low potential for G4 DNA formation, we evaluated the distribution of terms defined by the GO Consortium (<xref ref-type="bibr" rid="b49">49</xref>) for each RefSeq gene across the spectrum of G4 DNA potentials. In this classification scheme, 27% of genes currently have no GO terms assigned; and others have been assigned multiple GO terms and are represented in several different categories. The distribution of the 4396 GO terms assigned to the human RefSeq genes across G4 DNA potential proved to be nearly identical to the distribution of genes (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><p>Restricting further analysis to the 218 GO terms associated with 50 or more genes, 61 GO terms were identified for which 60% or more of the genes were below or above the RefSeq median G4P (24 low G4P and 37 high G4P); and application of the Wilcoxon rank sum test confirmed that these criteria were robust (<xref ref-type="table" rid="tbl1">Table 1</xref> and Supplementary Table 2). Functions characterized by low G4P include G-protein-coupled receptors, sensory perception (especially olfaction), nucleosome assembly, nucleic acid binding, ubiquitin cycle, cell adhesion and cell division; whereas functions characterized by high G4P include transcription factor activity, development, cell signaling, muscle contraction, growth factors and cytokines. <xref ref-type="fig" rid="fig2">Figure 2</xref> represents, for a subset of the GO terms identified with very low and very high G4P, the median and range of G4P relative to all RefSeq genes and all GO terms. In each case, the difference in distribution relative to the RefSeq genes was highly significant (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This establishes a relationship between specific gene functions and potential for G4 DNA formation.</p></sec><sec><title>Tumor suppressor genes are characterized by low G4P and proto-oncogenes by high G4P</title><p>Some of the gene functions characterized by low and high G4P (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="table" rid="tbl1">Table 1</xref>) are associated with tumor suppressor genes and proto-oncogenes, respectively. This led us to interrogate the distribution of G4P with respect to genes in these two categories. A list of 55 tumor suppressor genes and 95 proto-oncogenes was compiled (Supplementary Table 3), using the Online Mendelian Inheritance in Man (OMIM) database as a primary source and confirming gene classification by search of the published literature. Comparison of G4P for tumor suppressor genes and proto-oncogenes established a clear and highly significant difference in the range of G4P observed (Wilcoxon rank sum test, <italic>P</italic> = 10<sup>&#x02212;8</sup>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>), and in the distribution of G4P for genes in these two categories relative to the 16 654 genes in the RefSeq database (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The distribution of tumor suppressor genes was shifted from the RefSeq median of 5.0% towards low G4 DNA potential with a median of 2.4% (Wilcoxon rank sum test, <italic>P</italic> = 4 &#x000d7; 10<sup>&#x02212;5</sup>); and the distribution of proto-oncogenes was shifted towards high G4P with a median of 11.0% (Wilcoxon rank sum test, <italic>P</italic> = 7 &#x000d7; 10<sup>&#x02212;5</sup>).</p><p><xref ref-type="table" rid="tbl2">Table 2</xref> shows the top 10 genes in each category, ranked according to G4P, using a high stringency 40 nt search window. Analysis of G4P using a 40 nt rather than a 100 nt search window decreased the numerical value of G4P for each individual gene, as expected (<xref ref-type="table" rid="tbl2">Table 2</xref> and Supplementary Table 3), but did not affect the relative differences in distribution of the potentials, and further supported the significance of the difference between tumor suppressor genes and proto-oncogenes (Wilcoxon rank sum test, <italic>P</italic> = 2 &#x000d7; 10<sup>&#x02212;7</sup>). <xref ref-type="table" rid="tbl2">Table 2</xref> also shows representative GO terms assigned to each gene, many of which correspond to GO terms overrepresented in low or high G4P (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Simulations were carried out to verify the significance of the differences between G4P of tumor suppressor genes and proto-oncogenes. G4P distributions of 95 or 55 genes picked at random were not significantly different from the RefSeq set (<italic>P</italic> &#x0003e; 0.1), in each of 20 iterations. Furthermore, statistical significance of observed differences was robust to misclassification of up to 10 genes per category, as tested by the addition of 10 randomly selected RefSeq genes to either category (<italic>P</italic> &#x0003c; 0.002), or by elimination of 10 randomly selected genes from either category (<italic>P</italic> &#x0003c; 0.0002). These simulations confirmed the significance of the differences between G4P of tumor suppressor genes and proto-oncogenes.</p></sec><sec><title>Tumor suppressor genes and proto-oncogenes have similar numbers of CpG islands</title><p>CpG islands are associated with a majority of promoters of human genes (<xref ref-type="bibr" rid="b50">50</xref>), and CpG dinucleotides are targets for methylation leading to gene silencing [reviewed in (<xref ref-type="bibr" rid="b51">51</xref>)]. G4P is positively correlated with GC-content (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), which could in principle reflect a local enrichment of CpG methylation sites. We tested this possibility by analyzing tumor suppressor genes and proto-oncogenes with the EMBOSS program &#x02018;NewCpGReport&#x02019; (<xref ref-type="bibr" rid="b48">48</xref>), which identifies CpG-rich regions. The number of CpG-rich regions do not differ significantly between these two categories of genes (Wilcoxon rank sum test, <italic>P</italic> = 0.4; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Thus, the density of potential methylation sites does not distinguish tumor suppressor genes from proto-oncogenes, or account for the differences in G4P we have documented.</p></sec><sec><title>Both exon and intron sequences contribute to G4P</title><p>In human genes, the ratio of exon length to intron length is typically well below unity (<xref ref-type="bibr" rid="b52">52</xref>), so the measurement of G4P for an entire gene will largely reflect the contribution of intronic sequences. To distinguish contributions of exons and introns to G4P, we analyzed the G4P of one representative cDNA for each tumor suppressor gene and proto-oncogene (<xref ref-type="fig" rid="fig5">Figure 5</xref> and Supplementary Table 3). The median G4P of cDNA sequences is 1.9% for tumor suppressor genes, and 7.6% for proto-oncogenes (<xref ref-type="fig" rid="fig5">Figure 5</xref>), in each case slightly lower than G4P for the entire gene (2.4 and 11%, respectively; <xref ref-type="fig" rid="fig3">Figure 3B</xref>). The difference between G4P for cDNAs in the two functional categories is highly significant (Wilcoxon rank sum test, <italic>P</italic> = 6 &#x000d7; 10<sup>&#x02212;6</sup>). Thus, both exon and intron sequences contribute to the significant differences in G4P characteristic of tumor suppressor and proto-oncogenes.</p></sec><sec><title>The G4P of genes contrasts with their genomic environment</title><p>The human genome consists of large segments of fairly homogeneous GC-content, defined as isochores (<xref ref-type="bibr" rid="b53">53</xref>). With the availability of the human genome sequence, this definition has been honed further, and 100 kb segments of DNA sequence can be sorted into five isochore families with an average SD of &#x0223c;1% GC (<xref ref-type="bibr" rid="b54">54</xref>). Since G4P is positively correlated with GC-content (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we asked if G4P for each gene reflects its local genomic environment. To do this, we computed the difference in G4P for each of the RefSeq genes and its flanking sequences, &#x00394;G4P = G4P &#x02212; G4P<sub>FLANK</sub>, calculating G4P<sub>FLANK</sub> as the average G4P for 20 kb upstream and downstream of each gene (Supplementary Table 1 and <xref ref-type="fig" rid="fig6">Figure 6</xref>). The average &#x00394;G4P for all RefSeq genes is 1.6%; thus on average, genes have greater G4P than their flanking sequences. Comparison of &#x00394;G4P of the RefSeq genes, the proto-oncogenes and the tumor suppressor genes by a single-factor ANOVA showed that the three groups are distinct (ANOVA, <italic>P</italic> = 10<sup>&#x02212;5</sup>; <xref ref-type="fig" rid="fig6">Figure 6</xref>). The average &#x00394;G4P for the set of tumor suppressor genes is &#x02212;2.2%, much lower than that of the RefSeq genes (ANOVA, <italic>P</italic> = 5 &#x000d7; 10<sup>&#x02212;5</sup>). In contrast, the average &#x00394;G4P for the set of proto-oncogenes is 3.4%, higher than that of the RefSeq genes (ANOVA, <italic>P</italic> = 0.01), and considerably higher than that of the tumor suppressor genes (ANOVA, <italic>P</italic> = 5 &#x000d7; 10<sup>&#x02212;7</sup>). Thus, on average, tumor suppressor genes have lower G4P than their flanking sequences, and proto-oncogenes have higher G4P than their flanking sequences. Potential for G4 DNA formation therefore correlates with gene function, rather than local genomic environment, for both tumor suppressor genes and proto-oncogenes.</p><p>The prototypical tumor suppressor and proto-oncogenes, <italic>TP53</italic> and <italic>MYC</italic> [reviewed in (<xref ref-type="bibr" rid="b55">55</xref>)], illustrate the relationship between G4P of genes and their flanking sequences. For <italic>TP53</italic>, G4P is 7.6%, slightly higher than the RefSeq median of 5%; and G4P<sub>FLANK</sub> is 12.1% (10.0% upstream and 14.1% downstream). Thus, &#x00394;G4P of <italic>TP53</italic> is &#x02212;4.4%, low even among tumor suppressor genes. In contrast, for <italic>MYC</italic>, G4P is 18.6%, well above the RefSeq median; and G4P<sub>FLANK</sub> is 2.8% (3.3% upstream and 2.2% downstream). Thus, &#x00394;G4P of <italic>MYC</italic> is 15.9%, considerably above the average RefSeq &#x00394;G4P of 1.6%.</p></sec></sec><sec><title>DISCUSSION</title><p>We have investigated the relationship between potential to form G4 DNA and gene function for the 16&#x02009;654 human RefSeq genes. We find that there is a highly skewed distribution of G4P among human genes, and that there are robust correlations between G4P and gene function. Interrogation of the subset of 218 GO terms assigned to 50 or more genes showed that low G4P corresponds with functions including G-protein-coupled receptors, olfaction, nucleosome assembly, nucleic acid binding, ubiquitin cycle, cell adhesion and cell division; and high G4P with functions including transcription factor activity, development, cell signaling, growth factors and cytokines. These findings motivated interrogation of two contrasting gene categories defined by the OMIM database, tumor suppressor genes and proto-oncogenes, which showed that genes in these categories are distinguished by low and high G4P, respectively (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>In contrast to the robust relationship between G4P and gene function, G4P did not correspond to any of several well-established parameters used to characterize genomic structure. G4P does correlate with GC-content, but not with the number of CpG islands (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Both exons and introns contribute to the difference in G4P between tumor suppressor genes and proto-oncogenes (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Furthermore, G4P does not reflect the local genomic environment (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In fact, tumor suppressor genes have much lower G4P than would be predicted by their genomic environment as compared to the RefSeq genes, whereas proto-oncogenes have higher G4P than would be predicted. The most straightforward interpretation of these results is that genes with specific functions have undergone selection based on G4P.</p><p>One source of selective pressure that could contribute to determining G4P is suggested by the association between G-rich regions and genomic instability. Transcription-induced or replication-induced DNA structures can form within regions of high G4P, and if these structures are not faithfully resolved, the result may be genomic instability and impaired gene function. In this view, the low G4P of tumor suppressor genes could reflect evolution that minimized potential instability of genes which function to maintain genomic stability. There is considerable evidence for haploinsufficiency of tumor suppressor genes [reviewed in (<xref ref-type="bibr" rid="b56">56</xref>)], and this would contribute to pressure to minimize genomic instability. Conversely, the high G4P that characterizes the proto-oncogenes would be predicted to contribute to their destabilization. Could <italic>instability</italic> provide a selective advantage? Under some circumstances, it may. Proto-oncogenes are transcribed in rapidly dividing cells and tissues. Transcription-induced structures have considerable potential to contribute to genomic instability (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>), but they can form only within genes, which represent a relatively small fraction of genomic DNA. The high G4P of the proto-oncogenes would make them targets for transcription-induced destabilization. Proto-oncogenes encode key factors that promote cell proliferation and development, and impaired expression of a proto-oncogene could in turn diminish or prevent cell proliferation, either by decreasing expression of an essential factor, or signaling cell death via apoptosis. Proto-oncogenes may therefore carry out a passive surveillance function, monitoring instability that specifically affected the transcribed fraction of the genome. This surveillance function would necessarily be vested in genes, rather than in the vast landscape of nontranscribed sequences, consistent with the clear differences between G4P of genes and their flanking sequences.</p><p>Another mechanism that may contribute to selection based on G4P is shared regulation. Sequences within promoter regions of several proto-oncogenes have been shown to form G4 DNA <italic>in vitro</italic> (<xref ref-type="bibr" rid="b29">29</xref>&#x02013;<xref ref-type="bibr" rid="b32">32</xref>), and factors that bind G4 DNA have been implicated in both transcriptional and translational regulation (<xref ref-type="bibr" rid="b28">28</xref>,<xref ref-type="bibr" rid="b57">57</xref>). However, regulatory factors typically exert their effects within limited genomic regions, so commonality of short <italic>cis</italic>-regulatory elements is unlikely to provide a complete explanation for a feature of sequence composition that distinguishes both exons and introns, and extends throughout a gene (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Similarly, G4P is unlikely to reflect selection for coding capacity, as this sort of selection would affect exons alone. Nonetheless, there does appear to be some selection against regions of high G4P within exons, as in both gene categories, the median G4P of exons was lower than for introns: 1.9% versus 2.4% for tumor suppressor genes; and 7.6% versus 11% for proto-oncogenes (<xref ref-type="fig" rid="fig3">Figures 3B</xref> and <xref ref-type="fig" rid="fig5">5</xref>). Thus high G4P may be disfavored in mature RNAs, as has been proposed previously (<xref ref-type="bibr" rid="b4">4</xref>); or incompatible with efficient translation or effective coding.</p><p>Several lines of evidence suggest that GC-content may broadly correlate with gene expression levels (<xref ref-type="bibr" rid="b58">58</xref>&#x02013;<xref ref-type="bibr" rid="b60">60</xref>); in particular, GC-richness correlates with open chromatin structure, which may in turn facilitate transcription (<xref ref-type="bibr" rid="b61">61</xref>). Proto-oncogenes are rapidly transcribed during early development and in response to cell activation, and the high G4P of the proto-oncogenes might reflect GC-richness that contributes to high transcription levels of genes in this group. The finding that potential for G4 DNA formation correlates robustly with specific gene functions suggests that G4P may be a useful parameter to include in global analyses of gene expression, regulation and interactions. Systems-based analyses of this sort should establish whether regulation could contribute to selection based on G4P.</p></sec><sec><title>SUPPLEMENTARY DATA</title><p>Supplementary Data are available at NAR Online.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>[Supplementary Material]</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="nar_gkl529_index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="nar_gkl529_gkl529_Supplementary_Table_1.xls"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="nar_gkl529_gkl529_Supplementary_Table_2.xls"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="nar_gkl529_gkl529_Supplementary_Table_3.xls"/>
</supplementary-material>
</sec>
</body><back><ack><p>We thank Audrey Qiuyan Fu and Paul Sampson for assistance with statistical analysis; John Newman for independent testing of the G4P Calculator software; and Evan Eichler for comments on the manuscript. This work was supported by NIH R01 GM65988 to N.M. and J.E. was supported by T32 CA009537. Funding to pay the Open Access publication charges for this article was provided by NIH RO1 GM65988.</p><p><italic>Conflict of interest statement.</italic> None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="b1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>D.</given-names></name><name><surname>Gilbert</surname><given-names>W.</given-names></name></person-group><article-title>Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis</article-title><source>Nature</source><year>1988</year><volume>334</volume><fpage>364</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">3393228</pub-id></citation></ref><ref id="b2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gellert</surname><given-names>M.</given-names></name><name><surname>Lipsett</surname><given-names>M.N.</given-names></name><name><surname>Davies</surname><given-names>D.R.</given-names></name></person-group><article-title>Helix formation by guanylic acid</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1962</year><volume>48</volume><fpage>2013</fpage><lpage>2018</lpage><pub-id pub-id-type="pmid">13947099</pub-id></citation></ref><ref id="b3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>A.T.</given-names></name><name><surname>Kuryavyi</surname><given-names>V.</given-names></name><name><surname>Patel</surname><given-names>D.J.</given-names></name></person-group><article-title>DNA architecture: from G to Z</article-title><source>Curr. Opin. Struct. Biol.</source><year>2006</year><volume>16</volume><fpage>288</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">16714104</pub-id></citation></ref><ref id="b4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hazel</surname><given-names>P.</given-names></name><name><surname>Parkinson</surname><given-names>G.N.</given-names></name><name><surname>Neidle</surname><given-names>S.</given-names></name></person-group><article-title>Predictive modelling of topology and loop variations in dimeric DNA quadruplex structures</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>2117</fpage><lpage>2127</lpage><pub-id pub-id-type="pmid">16641317</pub-id></citation></ref><ref id="b5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huppert</surname><given-names>J.L.</given-names></name><name><surname>Balasubramanian</surname><given-names>S.</given-names></name></person-group><article-title>Prevalence of quadruplexes in the human genome</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>2908</fpage><lpage>2916</lpage><pub-id pub-id-type="pmid">15914667</pub-id></citation></ref><ref id="b6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>A.K.</given-names></name><name><surname>Johnston</surname><given-names>M.</given-names></name><name><surname>Neidle</surname><given-names>S.</given-names></name></person-group><article-title>Highly prevalent putative quadruplex sequence motifs in human DNA</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>2901</fpage><lpage>2907</lpage><pub-id pub-id-type="pmid">15914666</pub-id></citation></ref><ref id="b7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zahler</surname><given-names>A.M.</given-names></name><name><surname>Williamson</surname><given-names>J.R.</given-names></name><name><surname>Cech</surname><given-names>T.R.</given-names></name><name><surname>Prescott</surname><given-names>D.M.</given-names></name></person-group><article-title>Inhibition of telomerase by G-quartet DNA structures</article-title><source>Nature</source><year>1991</year><volume>350</volume><fpage>718</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">2023635</pub-id></citation></ref><ref id="b8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>F.</given-names></name><name><surname>Matunis</surname><given-names>M.J.</given-names></name><name><surname>Dreyfuss</surname><given-names>G.</given-names></name><name><surname>Cech</surname><given-names>T.R.</given-names></name></person-group><article-title>Nuclear proteins that bind the pre-mRNA 3&#x02032; splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)<italic><sub>n</sub></italic></article-title><source>Mol. Cell. Biol.</source><year>1993</year><volume>13</volume><fpage>4301</fpage><lpage>4310</lpage><pub-id pub-id-type="pmid">8321232</pub-id></citation></ref><ref id="b9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>T.M.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Salazar</surname><given-names>M.</given-names></name><name><surname>Hurley</surname><given-names>L.H.</given-names></name></person-group><article-title>Effect of DNA secondary structure on human telomerase activity</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>5536</fpage><lpage>5541</lpage><pub-id pub-id-type="pmid">9548937</pub-id></citation></ref><ref id="b10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaBranche</surname><given-names>H.</given-names></name><name><surname>Dupuis</surname><given-names>S.</given-names></name><name><surname>Ben-David</surname><given-names>Y.</given-names></name><name><surname>Bani</surname><given-names>M.-R.</given-names></name><name><surname>Wellinger</surname><given-names>R.J.</given-names></name><name><surname>Chabot</surname><given-names>B.</given-names></name></person-group><article-title>Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase</article-title><source>Nature Genet.</source><year>1998</year><volume>19</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9590273</pub-id></citation></ref><ref id="b11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eversole</surname><given-names>A.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title><italic>In vitro</italic> properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance</article-title><source>Mol. Cell. Biol.</source><year>2000</year><volume>20</volume><fpage>5425</fpage><lpage>5432</lpage><pub-id pub-id-type="pmid">10891483</pub-id></citation></ref><ref id="b12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enokizono</surname><given-names>Y.</given-names></name><name><surname>Konishi</surname><given-names>Y.</given-names></name><name><surname>Nagata</surname><given-names>K.</given-names></name><name><surname>Ouhashi</surname><given-names>K.</given-names></name><name><surname>Uesugi</surname><given-names>S.</given-names></name><name><surname>Ishikawa</surname><given-names>F.</given-names></name><name><surname>Katahira</surname><given-names>M.</given-names></name></person-group><article-title>Structure of hnRNP D complexed with single-stranded telomere DNA and unfolding of the quadruplex by heterogeneous nuclear ribonucleoprotein D</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>18862</fpage><lpage>18870</lpage><pub-id pub-id-type="pmid">15734733</pub-id></citation></ref><ref id="b13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paeschke</surname><given-names>K.</given-names></name><name><surname>Simonsson</surname><given-names>T.</given-names></name><name><surname>Postberg</surname><given-names>J.</given-names></name><name><surname>Rhodes</surname><given-names>D.</given-names></name><name><surname>Lipps</surname><given-names>H.J.</given-names></name></person-group><article-title>Telomere end-binding proteins control the formation of G-quadruplex DNA structures <italic>in vivo</italic></article-title><source>Nature Struct. Mol. Biol.</source><year>2005</year><volume>12</volume><fpage>847</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">16142245</pub-id></citation></ref><ref id="b14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaug</surname><given-names>A.J.</given-names></name><name><surname>Podell</surname><given-names>E.R.</given-names></name><name><surname>Cech</surname><given-names>T.R.</given-names></name></person-group><article-title>Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension <italic>in vitro</italic></article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>10864</fpage><lpage>10869</lpage><pub-id pub-id-type="pmid">16043710</pub-id></citation></ref><ref id="b15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.S.</given-names></name><name><surname>Manche</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>R.M.</given-names></name><name><surname>Krainer</surname><given-names>A.R.</given-names></name></person-group><article-title>hnRNP A1 associates with telomere ends and stimulates telomerase activity</article-title><source>RNA</source><year>2006</year><volume>12</volume><fpage>1116</fpage><lpage>1128</lpage><pub-id pub-id-type="pmid">16603717</pub-id></citation></ref><ref id="b16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>Immunoglobulin gene diversification</article-title><source>Annu. Rev. Genet.</source><year>2005</year><volume>39</volume><fpage>23</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16285851</pub-id></citation></ref><ref id="b17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>E.D.</given-names></name><name><surname>Duquette</surname><given-names>M.L.</given-names></name><name><surname>Cummings</surname><given-names>W.J.</given-names></name><name><surname>Streiff</surname><given-names>R.J.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions</article-title><source>Curr. Biol.</source><year>2005</year><volume>15</volume><fpage>470</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">15753043</pub-id></citation></ref><ref id="b18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasqualucci</surname><given-names>L.</given-names></name><name><surname>Neumeister</surname><given-names>P.</given-names></name><name><surname>Goossens</surname><given-names>T.</given-names></name><name><surname>Nanjangud</surname><given-names>G.</given-names></name><name><surname>Chaganti</surname><given-names>R.S.</given-names></name><name><surname>Kuppers</surname><given-names>R.</given-names></name><name><surname>Dalla-Favera</surname><given-names>R.</given-names></name></person-group><article-title>Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas</article-title><source>Nature</source><year>2001</year><volume>412</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">11460166</pub-id></citation></ref><ref id="b19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duquette</surname><given-names>M.L.</given-names></name><name><surname>Handa</surname><given-names>P.</given-names></name><name><surname>Vincent</surname><given-names>J.A.</given-names></name><name><surname>Taylor</surname><given-names>A.F.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA</article-title><source>Genes Dev.</source><year>2004</year><volume>18</volume><fpage>1618</fpage><lpage>1629</lpage><pub-id pub-id-type="pmid">15231739</pub-id></citation></ref><ref id="b20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duquette</surname><given-names>M.L.</given-names></name><name><surname>Pham</surname><given-names>P.</given-names></name><name><surname>Goodman</surname><given-names>M.F.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation</article-title><source>Oncogene</source><year>2005</year><volume>24</volume><fpage>5791</fpage><lpage>5798</lpage><pub-id pub-id-type="pmid">15940261</pub-id></citation></ref><ref id="b21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>Z.</given-names></name><name><surname>Wilson</surname><given-names>V.</given-names></name><name><surname>Patel</surname><given-names>I.</given-names></name><name><surname>Povey</surname><given-names>S.</given-names></name><name><surname>Jeffreys</surname><given-names>A.J.</given-names></name></person-group><article-title>Characterization of a panel of highly variable minisatellites cloned from human DNA</article-title><source>Ann. Hum. Genet.</source><year>1987</year><volume>51</volume><fpage>269</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">3482146</pub-id></citation></ref><ref id="b22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weitzmann</surname><given-names>M.N.</given-names></name><name><surname>Woodford</surname><given-names>K.J.</given-names></name><name><surname>Usdin</surname><given-names>K.</given-names></name></person-group><article-title>DNA secondary structures and the evolution of hypervariable tandem arrays</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>9517</fpage><lpage>9523</lpage><pub-id pub-id-type="pmid">9083093</pub-id></citation></ref><ref id="b23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kilburn</surname><given-names>A.E.</given-names></name><name><surname>Shea</surname><given-names>M.J.</given-names></name><name><surname>Sargent</surname><given-names>R.G.</given-names></name><name><surname>Wilson</surname><given-names>J.H.</given-names></name></person-group><article-title>Insertion of a telomere repeat sequence into a mammalian gene causes chromosome instability</article-title><source>Mol. Cell. Biol.</source><year>2001</year><volume>21</volume><fpage>126</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">11113187</pub-id></citation></ref><ref id="b24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reaban</surname><given-names>M.E.</given-names></name><name><surname>Griffin</surname><given-names>J.A.</given-names></name></person-group><article-title>Induction of RNA-stabilized DNA conformers by transcription of an immunoglobulin switch region</article-title><source>Nature</source><year>1990</year><volume>348</volume><fpage>342</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">1701219</pub-id></citation></ref><ref id="b25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizuta</surname><given-names>R.</given-names></name><name><surname>Iwai</surname><given-names>K.</given-names></name><name><surname>Shigeno</surname><given-names>M.</given-names></name><name><surname>Mizuta</surname><given-names>M.</given-names></name><name><surname>Ushiki</surname><given-names>T.</given-names></name><name><surname>Kitamura</surname><given-names>D.</given-names></name></person-group><article-title>Molecular visualization of immunoglobulin switch region RNA/DNA complex by atomic force microscope</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>278</volume><fpage>4431</fpage><lpage>4434</lpage><pub-id pub-id-type="pmid">12475983</pub-id></citation></ref><ref id="b26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huertas</surname><given-names>P.</given-names></name><name><surname>Aguilera</surname><given-names>A.</given-names></name></person-group><article-title>Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination</article-title><source>Mol. Cell</source><year>2003</year><volume>12</volume><fpage>711</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">14527416</pub-id></citation></ref><ref id="b27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Manley</surname><given-names>J.L.</given-names></name></person-group><article-title>Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">16096057</pub-id></citation></ref><ref id="b28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J.C.</given-names></name><name><surname>Fraser</surname><given-names>C.E.</given-names></name><name><surname>Mostovetsky</surname><given-names>O.</given-names></name><name><surname>Stefani</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>T.A.</given-names></name><name><surname>Eddy</surname><given-names>S.R.</given-names></name><name><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group><article-title>Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes</article-title><source>Genes Dev.</source><year>2005</year><volume>19</volume><fpage>903</fpage><lpage>918</lpage><pub-id pub-id-type="pmid">15805463</pub-id></citation></ref><ref id="b29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J.C.</given-names></name><name><surname>Jensen</surname><given-names>K.B.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name><name><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group><article-title>Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function</article-title><source>Cell</source><year>2001</year><volume>107</volume><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">11719189</pub-id></citation></ref><ref id="b30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simonsson</surname><given-names>T.</given-names></name><name><surname>Pecinka</surname><given-names>P.</given-names></name><name><surname>Kubista</surname><given-names>M.</given-names></name></person-group><article-title>DNA tetraplex formation in the control region of c-myc</article-title><source>Nucleic Acids Res.</source><year>1998</year><volume>26</volume><fpage>1167</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">9469822</pub-id></citation></ref><ref id="b31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Guo</surname><given-names>K.</given-names></name><name><surname>Rusche</surname><given-names>J.J.</given-names></name><name><surname>Hurley</surname><given-names>L.H.</given-names></name></person-group><article-title>Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>6070</fpage><lpage>6080</lpage><pub-id pub-id-type="pmid">16239639</pub-id></citation></ref><ref id="b32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>S.</given-names></name><name><surname>Reszka</surname><given-names>A.P.</given-names></name><name><surname>Huppert</surname><given-names>J.</given-names></name><name><surname>Zloh</surname><given-names>M.</given-names></name><name><surname>Parkinson</surname><given-names>G.N.</given-names></name><name><surname>Todd</surname><given-names>A.K.</given-names></name><name><surname>Ladame</surname><given-names>S.</given-names></name><name><surname>Balasubramanian</surname><given-names>S.</given-names></name><name><surname>Neidle</surname><given-names>S.</given-names></name></person-group><article-title>Putative DNA quadruplex formation within the human c-kit oncogene</article-title><source>J. Am. Chem. Soc.</source><year>2005</year><volume>127</volume><fpage>10584</fpage><lpage>10589</lpage><pub-id pub-id-type="pmid">16045346</pub-id></citation></ref><ref id="b33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Dexheimer</surname><given-names>T.S.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Carver</surname><given-names>M.</given-names></name><name><surname>Ambrus</surname><given-names>A.</given-names></name><name><surname>Jones</surname><given-names>R.A.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name></person-group><article-title>An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution</article-title><source>J. Am. Chem. Soc.</source><year>2006</year><volume>128</volume><fpage>1096</fpage><lpage>1098</lpage><pub-id pub-id-type="pmid">16433524</pub-id></citation></ref><ref id="b34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rezler</surname><given-names>E.M.</given-names></name><name><surname>Bearss</surname><given-names>D.J.</given-names></name><name><surname>Hurley</surname><given-names>L.H.</given-names></name></person-group><article-title>Telomere inhibition and telomere disruption as processes for drug targeting</article-title><source>Annu. Rev. Pharmacol. Toxicol.</source><year>2003</year><volume>43</volume><fpage>359</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">12540745</pub-id></citation></ref><ref id="b35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>D.</given-names></name><name><surname>Lemarteleur</surname><given-names>T.</given-names></name><name><surname>Lacroix</surname><given-names>L.</given-names></name><name><surname>Mailliet</surname><given-names>P.</given-names></name><name><surname>Mergny</surname><given-names>J.L.</given-names></name><name><surname>Riou</surname><given-names>J.F.</given-names></name></person-group><article-title>Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing</article-title><source>Nucleic Acids Res.</source><year>2004</year><volume>32</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">14729921</pub-id></citation></ref><ref id="b36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>A.M.</given-names></name><name><surname>Dai</surname><given-names>F.</given-names></name><name><surname>Schultes</surname><given-names>C.M.</given-names></name><name><surname>Reszka</surname><given-names>A.P.</given-names></name><name><surname>Moore</surname><given-names>M.J.</given-names></name><name><surname>Double</surname><given-names>J.A.</given-names></name><name><surname>Neidle</surname><given-names>S.</given-names></name></person-group><article-title>The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function</article-title><source>Cancer Res.</source><year>2005</year><volume>65</volume><fpage>1489</fpage><lpage>1496</lpage><pub-id pub-id-type="pmid">15735037</pub-id></citation></ref><ref id="b37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tauchi</surname><given-names>T.</given-names></name><name><surname>Shin-Ya</surname><given-names>K.</given-names></name><name><surname>Sashida</surname><given-names>G.</given-names></name><name><surname>Sumi</surname><given-names>M.</given-names></name><name><surname>Okabe</surname><given-names>S.</given-names></name><name><surname>Ohyashiki</surname><given-names>J.H.</given-names></name><name><surname>Ohyashiki</surname><given-names>K.</given-names></name></person-group><article-title>Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: <italic>in vitro</italic> and <italic>in vivo</italic>studies in acute leukemia</article-title><source>Oncogene</source><year>2006</year><comment>(in press).</comment></citation></ref><ref id="b38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui-Jain</surname><given-names>A.</given-names></name><name><surname>Grand</surname><given-names>C.L.</given-names></name><name><surname>Bearss</surname><given-names>D.J.</given-names></name><name><surname>Hurley</surname><given-names>L.H.</given-names></name></person-group><article-title>Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2002</year><volume>99</volume><fpage>11593</fpage><lpage>11598</lpage><pub-id pub-id-type="pmid">12195017</pub-id></citation></ref><ref id="b39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cogoi</surname><given-names>S.</given-names></name><name><surname>Xodo</surname><given-names>L.E.</given-names></name></person-group><article-title>G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>2536</fpage><lpage>2549</lpage><pub-id pub-id-type="pmid">16687659</pub-id></citation></ref><ref id="b40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>M.D.</given-names></name><name><surname>Lee</surname><given-names>D.C.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate-specific inhibition</article-title><source>Nucleic Acids Res.</source><year>2002</year><volume>30</volume><fpage>3954</fpage><lpage>3961</lpage><pub-id pub-id-type="pmid">12235379</pub-id></citation></ref><ref id="b41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>M.</given-names></name><name><surname>Loeb</surname><given-names>L.A.</given-names></name></person-group><article-title>Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n</article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>12797</fpage><lpage>12802</lpage><pub-id pub-id-type="pmid">10212265</pub-id></citation></ref><ref id="b42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Bennett</surname><given-names>R.J.</given-names></name><name><surname>Maizels</surname><given-names>N.</given-names></name></person-group><article-title>The <italic>S. cerevisiae</italic> Sgs1 helicase efficiently unwinds G&#x02013;G paired DNAs</article-title><source>Nucleic Acids Res.</source><year>1999</year><volume>27</volume><fpage>1978</fpage><lpage>1984</lpage><pub-id pub-id-type="pmid">10198430</pub-id></citation></ref><ref id="b43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>D.A.</given-names></name><name><surname>Guarente</surname><given-names>L.</given-names></name></person-group><article-title>Extrachromosomal rDNA circles&#x02014;a cause of aging in yeast</article-title><source>Cell</source><year>1997</year><volume>91</volume><fpage>1033</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">9428525</pub-id></citation></ref><ref id="b44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Versini</surname><given-names>G.</given-names></name><name><surname>Comet</surname><given-names>I.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Hoopes</surname><given-names>L.</given-names></name><name><surname>Schwob</surname><given-names>E.</given-names></name><name><surname>Pasero</surname><given-names>P.</given-names></name></person-group><article-title>The yeast Sgs1 helicase is differentially required for genomic and ribosomal DNA replication</article-title><source>EMBO J.</source><year>2003</year><volume>22</volume><fpage>1939</fpage><lpage>1949</lpage><pub-id pub-id-type="pmid">12682026</pub-id></citation></ref><ref id="b45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crabbe</surname><given-names>L.</given-names></name><name><surname>Verdun</surname><given-names>R.E.</given-names></name><name><surname>Haggblom</surname><given-names>C.I.</given-names></name><name><surname>Karlseder</surname><given-names>J.</given-names></name></person-group><article-title>Defective telomere lagging strand synthesis in cells lacking WRN helicase activity</article-title><source>Science</source><year>2004</year><volume>306</volume><fpage>1951</fpage><lpage>1953</lpage><pub-id pub-id-type="pmid">15591207</pub-id></citation></ref><ref id="b46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>X.W.</given-names></name><name><surname>Linke</surname><given-names>S.P.</given-names></name><name><surname>Sengupta</surname><given-names>S.</given-names></name><name><surname>Hickson</surname><given-names>I.D.</given-names></name><name><surname>Pedrazzi</surname><given-names>G.</given-names></name><name><surname>Perrera</surname><given-names>C.</given-names></name><name><surname>Stagljar</surname><given-names>I.</given-names></name><name><surname>Littman</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>3749</fpage><lpage>3756</lpage><pub-id pub-id-type="pmid">15064730</pub-id></citation></ref><ref id="b47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>T.</given-names></name><name><surname>Andrews</surname><given-names>D.</given-names></name><name><surname>Caccamo</surname><given-names>M.</given-names></name><name><surname>Cameron</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Clamp</surname><given-names>M.</given-names></name><name><surname>Clarke</surname><given-names>L.</given-names></name><name><surname>Coates</surname><given-names>G.</given-names></name><name><surname>Cox</surname><given-names>T.</given-names></name><name><surname>Cunningham</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Ensembl 2005</article-title><source>Nucleic Acids Res.</source><year>2005</year><volume>33</volume><fpage>D447</fpage><lpage>D453</lpage><pub-id pub-id-type="pmid">15608235</pub-id></citation></ref><ref id="b48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>P.</given-names></name><name><surname>Longden</surname><given-names>I.</given-names></name><name><surname>Bleasby</surname><given-names>A.</given-names></name></person-group><article-title>EMBOSS: the European Molecular Biology Open Software Suite</article-title><source>Trends Genet.</source><year>2000</year><volume>16</volume><fpage>276</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">10827456</pub-id></citation></ref><ref id="b49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>C.A.</given-names></name><name><surname>Blake</surname><given-names>J.A.</given-names></name><name><surname>Botstein</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>H.</given-names></name><name><surname>Cherry</surname><given-names>J.M.</given-names></name><name><surname>Davis</surname><given-names>A.P.</given-names></name><name><surname>Dolinski</surname><given-names>K.</given-names></name><name><surname>Dwight</surname><given-names>S.S.</given-names></name><name><surname>Eppig</surname><given-names>J.T.</given-names></name><etal/></person-group><article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title><source>Nature Genet.</source><year>2000</year><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">10802651</pub-id></citation></ref><ref id="b50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carninci</surname><given-names>P.</given-names></name><name><surname>Sandelin</surname><given-names>A.</given-names></name><name><surname>Lenhard</surname><given-names>B.</given-names></name><name><surname>Katayama</surname><given-names>S.</given-names></name><name><surname>Shimokawa</surname><given-names>K.</given-names></name><name><surname>Ponjavic</surname><given-names>J.</given-names></name><name><surname>Semple</surname><given-names>C.A.</given-names></name><name><surname>Taylor</surname><given-names>M.S.</given-names></name><name><surname>Engstrom</surname><given-names>P.G.</given-names></name><name><surname>Frith</surname><given-names>M.C.</given-names></name><etal/></person-group><article-title>Genome-wide analysis of mammalian promoter architecture and evolution</article-title><source>Nature Genet.</source><year>2006</year><volume>38</volume><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">16645617</pub-id></citation></ref><ref id="b51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>R.J.</given-names></name><name><surname>Bird</surname><given-names>A.P.</given-names></name></person-group><article-title>Genomic DNA methylation: the mark and its mediators</article-title><source>Trends Biochem. Sci.</source><year>2006</year><volume>31</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">16403636</pub-id></citation></ref><ref id="b52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>E.S.</given-names></name><name><surname>Linton</surname><given-names>L.M.</given-names></name><name><surname>Birren</surname><given-names>B.</given-names></name><name><surname>Nusbaum</surname><given-names>C.</given-names></name><name><surname>Zody</surname><given-names>M.C.</given-names></name><name><surname>Baldwin</surname><given-names>J.</given-names></name><name><surname>Devon</surname><given-names>K.</given-names></name><name><surname>Dewar</surname><given-names>K.</given-names></name><name><surname>Doyle</surname><given-names>M.</given-names></name><name><surname>FitzHugh</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Initial sequencing and analysis of the human genome</article-title><source>Nature</source><year>2001</year><volume>409</volume><fpage>860</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">11237011</pub-id></citation></ref><ref id="b53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>G.</given-names></name><name><surname>Olofsson</surname><given-names>B.</given-names></name><name><surname>Filipski</surname><given-names>J.</given-names></name><name><surname>Zerial</surname><given-names>M.</given-names></name><name><surname>Salinas</surname><given-names>J.</given-names></name><name><surname>Cuny</surname><given-names>G.</given-names></name><name><surname>Meunier-Rotival</surname><given-names>M.</given-names></name><name><surname>Rodier</surname><given-names>F.</given-names></name></person-group><article-title>The mosaic genome of warm-blooded vertebrates</article-title><source>Science</source><year>1985</year><volume>228</volume><fpage>953</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">4001930</pub-id></citation></ref><ref id="b54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costantini</surname><given-names>M.</given-names></name><name><surname>Clay</surname><given-names>O.</given-names></name><name><surname>Auletta</surname><given-names>F.</given-names></name><name><surname>Bernardi</surname><given-names>G.</given-names></name></person-group><article-title>An isochore map of human chromosomes</article-title><source>Genome Res.</source><year>2006</year><volume>16</volume><fpage>536</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">16597586</pub-id></citation></ref><ref id="b55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>The hallmarks of cancer</article-title><source>Cell</source><year>2000</year><volume>100</volume><fpage>57</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10647931</pub-id></citation></ref><ref id="b56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>S.R.</given-names></name><name><surname>Kemp</surname><given-names>C.J.</given-names></name></person-group><article-title>Tumor suppressor genetics</article-title><source>Carcinogenesis</source><year>2005</year><volume>26</volume><fpage>2031</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">16150895</pub-id></citation></ref><ref id="b57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname><given-names>A.</given-names></name><name><surname>Rutter</surname><given-names>W.J.</given-names></name><name><surname>Kennedy</surname><given-names>G.C.</given-names></name></person-group><article-title>Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>12508</fpage><lpage>12512</lpage><pub-id pub-id-type="pmid">11070077</pub-id></citation></ref><ref id="b58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Versteeg</surname><given-names>R.</given-names></name><name><surname>van Schaik</surname><given-names>B.D.</given-names></name><name><surname>van Batenburg</surname><given-names>M.F.</given-names></name><name><surname>Roos</surname><given-names>M.</given-names></name><name><surname>Monajemi</surname><given-names>R.</given-names></name><name><surname>Caron</surname><given-names>H.</given-names></name><name><surname>Bussemaker</surname><given-names>H.J.</given-names></name><name><surname>van Kampen</surname><given-names>A.H.</given-names></name></person-group><article-title>The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes</article-title><source>Genome Res.</source><year>2003</year><volume>13</volume><fpage>1998</fpage><lpage>2004</lpage><pub-id pub-id-type="pmid">12915492</pub-id></citation></ref><ref id="b59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lercher</surname><given-names>M.J.</given-names></name><name><surname>Urrutia</surname><given-names>A.O.</given-names></name><name><surname>Pavlicek</surname><given-names>A.</given-names></name><name><surname>Hurst</surname><given-names>L.D.</given-names></name></person-group><article-title>A unification of mosaic structures in the human genome</article-title><source>Hum. Mol. Genet.</source><year>2003</year><volume>12</volume><fpage>2411</fpage><lpage>2415</lpage><pub-id pub-id-type="pmid">12915446</pub-id></citation></ref><ref id="b60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semon</surname><given-names>M.</given-names></name><name><surname>Mouchiroud</surname><given-names>D.</given-names></name><name><surname>Duret</surname><given-names>L.</given-names></name></person-group><article-title>Relationship between gene expression and GC-content in mammals: statistical significance and biological relevance</article-title><source>Hum. Mol. Genet.</source><year>2005</year><volume>14</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">15590696</pub-id></citation></ref><ref id="b61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>N.</given-names></name><name><surname>Boyle</surname><given-names>S.</given-names></name><name><surname>Fiegler</surname><given-names>H.</given-names></name><name><surname>Woodfine</surname><given-names>K.</given-names></name><name><surname>Carter</surname><given-names>N.P.</given-names></name><name><surname>Bickmore</surname><given-names>W.A.</given-names></name></person-group><article-title>Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">15339661</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Potential for G4 DNA formation of human genes. (<bold>A</bold>) Distribution of genes across G4 DNA formation potential (G4P). The distribution of 16 654 RefSeq genes is illustrated by vertical bars (gray). Median G4P for the RefSeq genes at 5.0% is indicated by a dotted line. The distribution of the 4396 GO terms assigned to 73% of the RefSeq genes is outlined (black). (<bold>B</bold>) Positive correlation of G4P of template and nontemplate DNA strands. Linear regression analysis of G4P of the nontemplate (<italic>y</italic>-axis) and the template (<italic>x</italic>-axis) strand. Owing to the skewed distribution of G4P, the data were subjected to a natural log transformation before linear regression analysis; therefore, a small number of genes with G4P equal to zero were not included. The slope determined by linear regression analysis (0.83) is represented by the solid line; and slope of unity by the dotted line.</p></caption><graphic xlink:href="gkl529f1"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>G4P correlates with gene function. Ranges of G4P for all RefSeq genes (top line) compared with five GO terms overrepresented in low or high G4P. Boxes represent the percentage of genes in each GO category characterized by G4P in the range 0&#x02013;1.25, 1.25&#x02013;2.5, 2.5&#x02013;5.0, 5&#x02013;10, 10&#x02013;20% and &#x0003e;20% (colors as indicated). <italic>P</italic>-values shown on the right represent significance of the difference in distribution between each GO term and the RefSeq genes, as calculated by the Wilcoxon rank sum test.</p></caption><graphic xlink:href="gkl529f2"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Contrasting G4P of tumor suppressor genes and proto-oncogenes. (<bold>A</bold>) Ranges of G4P for 55 tumor suppressor genes, 95 proto-oncogenes and all 16 654 RefSeq genes. Boxes represent the percentage of genes in each category characterized by G4P in the range 0&#x02013;1.25, 1.25&#x02013;2.5, 2.5&#x02013;5.0, 5&#x02013;10, 10&#x02013;20% and &#x0003e;20% (colors as indicated). <italic>P</italic>-value represents significance of the difference in distribution between the tumor suppressor genes and proto-oncogenes, as calculated by the Wilcoxon rank sum test. (<bold>B</bold>) Distribution of tumor suppressor genes and proto-oncogenes across G4P. Bars represent the G4P distribution of 55 tumor suppressor genes (blue) and 95 proto-oncogenes (red). The black outline diagrams distribution of all 16 654 RefSeq genes (as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>). <italic>P</italic>-values represent significance of the difference in distribution between each group of genes and the RefSeq genes, as calculated by the Wilcoxon rank sum test.</p></caption><graphic xlink:href="gkl529f3"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>G4P correlates with GC-content but not CpG islands. (<bold>A</bold>) Correlation of G4P with GC-content. Linear regression analysis of G4P relative to total GC-content (left); the portion of GC-content contributed from G-runs or C-runs (center); the remaining GC-content contributed from Gs and Cs outside of G-runs or C-runs (right). The data were subjected to a natural log transformation before linear regression analysis; therefore, a small number of genes with G4P equal to zero were not included. The slopes determined by linear regression analysis are represented by solid lines. G4P correlates most closely with Gs and Cs within runs (middle). (<bold>B</bold>) Distribution of tumor suppressor genes and proto-oncogenes relative to number of CpG islands. Closed bars, tumor suppressor genes; open bars, proto-oncogenes. <italic>P</italic>-value was determined by the Wilcoxon rank sum test comparing tumor suppressor genes to proto-oncogenes, and shows that there is not a significant relationship between gene function and number of CpG islands.</p></caption><graphic xlink:href="gkl529f4"/></fig><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Differences in G4P of tumor suppressor and proto-oncogene cDNAs. Distribution of tumor suppressor gene and proto-oncogene cDNA sequences across G4P. Bars represent tumor suppressor genes (closed bars) and proto-oncogenes (open bars). <italic>P</italic>-value was determined from the Wilcoxon rank sum test comparing tumor suppressor genes to proto-oncogenes.</p></caption><graphic xlink:href="gkl529f5"/></fig><fig id="fig6" position="float"><label>Figure 6</label><caption><p>G4P of genes differs from G4P of genomic environment. Average G4P for genes; 20 kb flanking sequences (G4P<sub>FLANK</sub>); and &#x00394;G4P, the difference between G4P for each gene and its flank. Gray bars, RefSeq genes; closed bars, tumor suppressor genes; and open bars, proto-oncogenes. Standard errors were determined by ANOVA for each analysis of the three groups of genes.</p></caption><graphic xlink:href="gkl529f6"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Gene Ontology (GO) terms with low and high G4P</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="3" align="left" rowspan="1"><underline>Biological process</underline></th><th colspan="3" align="left" rowspan="1"><underline>Molecular function</underline></th><th rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">GO ID</th><th align="left" rowspan="1" colspan="1">GO description</th><th align="left" rowspan="1" colspan="1">No. of genes</th><th align="left" rowspan="1" colspan="1"><italic>P</italic></th><th align="left" rowspan="1" colspan="1">GO ID</th><th align="left" rowspan="1" colspan="1">GO description</th><th align="left" rowspan="1" colspan="1">No. of genes</th><th align="left" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="8" align="left" rowspan="1"><underline>Low G4P</underline></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007186</td><td align="left" rowspan="1" colspan="1">G-protein-coupled receptor protein signaling pathway</td><td align="left" rowspan="1" colspan="1">674</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td><td align="left" rowspan="1" colspan="1">GO:0004984</td><td align="left" rowspan="1" colspan="1">Olfactory receptor activity</td><td align="left" rowspan="1" colspan="1">316</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007600</td><td align="left" rowspan="1" colspan="1">Sensory perception</td><td align="left" rowspan="1" colspan="1">436</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td><td align="left" rowspan="1" colspan="1">GO:0003676</td><td align="left" rowspan="1" colspan="1">Nucleic acid binding</td><td align="left" rowspan="1" colspan="1">615</td><td align="left" rowspan="1" colspan="1">1E&#x02212;06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007608</td><td align="left" rowspan="1" colspan="1">Perception of smell</td><td align="left" rowspan="1" colspan="1">244</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td><td align="left" rowspan="1" colspan="1">GO:0005488</td><td align="left" rowspan="1" colspan="1">Binding</td><td align="left" rowspan="1" colspan="1">427</td><td align="left" rowspan="1" colspan="1">5E&#x02212;06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007001</td><td align="left" rowspan="1" colspan="1">Chromosome organization and biogenesis</td><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">8E&#x02212;11</td><td align="left" rowspan="1" colspan="1">GO:0016874</td><td align="left" rowspan="1" colspan="1">Ligase activity</td><td align="left" rowspan="1" colspan="1">163</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006334</td><td align="left" rowspan="1" colspan="1">Nucleosome assembly</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">9E&#x02212;11</td><td align="left" rowspan="1" colspan="1">GO:0004197</td><td align="left" rowspan="1" colspan="1">Cysteine-type endopeptidase activity</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006511</td><td align="left" rowspan="1" colspan="1">Ubiquitin-dependent protein catabolism</td><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">5E&#x02212;05</td><td align="left" rowspan="1" colspan="1">GO:0004842</td><td align="left" rowspan="1" colspan="1">Ubiquitin&#x02013;protein ligase activity</td><td align="left" rowspan="1" colspan="1">327</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006512</td><td align="left" rowspan="1" colspan="1">Ubiquitin cycle</td><td align="left" rowspan="1" colspan="1">210</td><td align="left" rowspan="1" colspan="1">0.0002</td><td align="left" rowspan="1" colspan="1">GO:0017111</td><td align="left" rowspan="1" colspan="1">Nucleoside triphosphatase activity</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007156</td><td align="left" rowspan="1" colspan="1">Homophilic cell adhesion</td><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">GO:0008026</td><td align="left" rowspan="1" colspan="1">ATP-dependent helicase activity</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0051301</td><td align="left" rowspan="1" colspan="1">Cell division</td><td align="left" rowspan="1" colspan="1">119</td><td align="left" rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006470</td><td align="left" rowspan="1" colspan="1">Protein amino acid dephosphorylation</td><td align="left" rowspan="1" colspan="1">115</td><td align="left" rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td colspan="8" align="left" rowspan="1"><underline>High G4P</underline></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007275</td><td align="left" rowspan="1" colspan="1">Development</td><td align="left" rowspan="1" colspan="1">391</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td><td align="left" rowspan="1" colspan="1">GO:0003700</td><td align="left" rowspan="1" colspan="1">Transcription factor activity</td><td align="left" rowspan="1" colspan="1">752</td><td align="left" rowspan="1" colspan="1">&#x0003c; 2E&#x02212;16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006955</td><td align="left" rowspan="1" colspan="1">Immune response</td><td align="left" rowspan="1" colspan="1">272</td><td align="left" rowspan="1" colspan="1">3E&#x02212;09</td><td align="left" rowspan="1" colspan="1">GO:0004295</td><td align="left" rowspan="1" colspan="1">Trypsin activity</td><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">2E&#x02212;07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007267</td><td align="left" rowspan="1" colspan="1">Cell&#x02013;cell signaling</td><td align="left" rowspan="1" colspan="1">263</td><td align="left" rowspan="1" colspan="1">2E&#x02212;06</td><td align="left" rowspan="1" colspan="1">GO:0004263</td><td align="left" rowspan="1" colspan="1">Chymotrypsin activity</td><td align="left" rowspan="1" colspan="1">91</td><td align="left" rowspan="1" colspan="1">9E&#x02212;07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006936</td><td align="left" rowspan="1" colspan="1">Muscle contraction</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">6E&#x02212;05</td><td align="left" rowspan="1" colspan="1">GO:0030528</td><td align="left" rowspan="1" colspan="1">Transcription regulator activity</td><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">8E&#x02212;05</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006817</td><td align="left" rowspan="1" colspan="1">Phosphate transport</td><td align="left" rowspan="1" colspan="1">80</td><td align="left" rowspan="1" colspan="1">7E&#x02212;05</td><td align="left" rowspan="1" colspan="1">GO:0030955</td><td align="left" rowspan="1" colspan="1">Potassium ion binding</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007010</td><td align="left" rowspan="1" colspan="1">Cytoskeleton organization and biogenesis</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">0.0002</td><td align="left" rowspan="1" colspan="1">GO:0008083</td><td align="left" rowspan="1" colspan="1">Growth factor activity</td><td align="left" rowspan="1" colspan="1">116</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0009653</td><td align="left" rowspan="1" colspan="1">Morphogenesis</td><td align="left" rowspan="1" colspan="1">104</td><td align="left" rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">GO:0005179</td><td align="left" rowspan="1" colspan="1">Hormone activity</td><td align="left" rowspan="1" colspan="1">80</td><td align="left" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007517</td><td align="left" rowspan="1" colspan="1">Muscle development</td><td align="left" rowspan="1" colspan="1">103</td><td align="left" rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">GO:0008289</td><td align="left" rowspan="1" colspan="1">Lipid binding</td><td align="left" rowspan="1" colspan="1">75</td><td align="left" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007218</td><td align="left" rowspan="1" colspan="1">Neuropeptide signaling pathway</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">GO:0003774</td><td align="left" rowspan="1" colspan="1">Motor activity</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006814</td><td align="left" rowspan="1" colspan="1">Sodium ion transport</td><td align="left" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">GO:0015293</td><td align="left" rowspan="1" colspan="1">Symporter activity</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006968</td><td align="left" rowspan="1" colspan="1">Cellular defense response</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">GO:0005249</td><td align="left" rowspan="1" colspan="1">Voltage-gated potassium channel activity</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006954</td><td align="left" rowspan="1" colspan="1">Inflammatory response</td><td align="left" rowspan="1" colspan="1">163</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">GO:0005125</td><td align="left" rowspan="1" colspan="1">Cytokine activity</td><td align="left" rowspan="1" colspan="1">79</td><td align="left" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006091</td><td align="left" rowspan="1" colspan="1">Generation of precursor metabolites and energy</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">GO:0020037</td><td align="left" rowspan="1" colspan="1">Heme binding</td><td align="left" rowspan="1" colspan="1">78</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0001501</td><td align="left" rowspan="1" colspan="1">Skeletal development</td><td align="left" rowspan="1" colspan="1">78</td><td align="left" rowspan="1" colspan="1">0.03</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0007169</td><td align="left" rowspan="1" colspan="1">Transmembrane receptor protein tyrosine kinase signaling pathway</td><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0008544</td><td align="left" rowspan="1" colspan="1">Epidermis development</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">0.04</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006816</td><td align="left" rowspan="1" colspan="1">Calcium ion transport</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0006869</td><td align="left" rowspan="1" colspan="1">Lipid transport</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">0.08</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;GO:0009887</td><td align="left" rowspan="1" colspan="1">Organogenesis</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>GO term ID number, description and number of genes to which this term applies, for each GO term associated with Biological Processes and Molecular Functions, and containing genes with a distribution that is significantly lower or higher in G4P than the RefSeq genes. Terms are sorted by ascending <italic>P</italic>-value (shown) as calculated by the Wilcoxon rank sum test. Additional data can be found in Supplementary Table 2.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Tumor suppressor genes with low G4P and proto-oncogenes with high G4P</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="left" rowspan="1">Tumor suppressor genes</th><th colspan="4" align="left" rowspan="1">Proto-oncogenes</th></tr><tr><th align="left" rowspan="1" colspan="1">HGNC symbol</th><th align="left" rowspan="1" colspan="1">G4P, 100 nt window (%)</th><th align="left" rowspan="1" colspan="1">G4P, 40 nt window (%)</th><th align="left" rowspan="1" colspan="1">Representative GO terms</th><th align="left" rowspan="1" colspan="1">HGNC symbol</th><th align="left" rowspan="1" colspan="1">G4P, 100 nt window (%)</th><th align="left" rowspan="1" colspan="1">G4P, 40 nt window (%)</th><th align="left" rowspan="1" colspan="1">Representative GO terms</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>FBXW7</italic></td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Protein ubiquitination</td><td align="left" rowspan="1" colspan="1"><italic>FGF4</italic></td><td align="left" rowspan="1" colspan="1">46.6</td><td align="left" rowspan="1" colspan="1">6.8</td><td align="left" rowspan="1" colspan="1">Cell&#x02013;cell signaling, growth factor activity</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MAD2L1</italic></td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Cell cycle, cell division</td><td align="left" rowspan="1" colspan="1"><italic>AKT1</italic></td><td align="left" rowspan="1" colspan="1">45.9</td><td align="left" rowspan="1" colspan="1">5.3</td><td align="left" rowspan="1" colspan="1">Anti-apoptosis, signal transduction</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>SMARCA3</italic></td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Ubiquitin&#x02013;protein ligase activity, DNA binding</td><td align="left" rowspan="1" colspan="1"><italic>HRAS</italic></td><td align="left" rowspan="1" colspan="1">37.6</td><td align="left" rowspan="1" colspan="1">4.3</td><td align="left" rowspan="1" colspan="1">Organogenesis, GTPase activity</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>APC</italic></td><td align="left" rowspan="1" colspan="1">1.1</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Cell adhesion, negative regulation of cell cycle</td><td align="left" rowspan="1" colspan="1"><italic>IGF2</italic></td><td align="left" rowspan="1" colspan="1">31.6</td><td align="left" rowspan="1" colspan="1">4.1</td><td align="left" rowspan="1" colspan="1">Development, growth factor activity, hormone activity</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>BLM</italic></td><td align="left" rowspan="1" colspan="1">1.4</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">DNA binding, DNA repair</td><td align="left" rowspan="1" colspan="1"><italic>BCL3</italic></td><td align="left" rowspan="1" colspan="1">25.4</td><td align="left" rowspan="1" colspan="1">4.1</td><td align="left" rowspan="1" colspan="1">Transcription, regulation of cell cycle</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>THBS1</italic></td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Cell adhesion, cell motility</td><td align="left" rowspan="1" colspan="1"><italic>NOTCH1</italic></td><td align="left" rowspan="1" colspan="1">39.2</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="left" rowspan="1" colspan="1">Transcription factor activity, epidermis development</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>VHL</italic></td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Protein ubiquitination, negative regulation of cell cycle</td><td align="left" rowspan="1" colspan="1"><italic>NFKB2</italic></td><td align="left" rowspan="1" colspan="1">27.6</td><td align="left" rowspan="1" colspan="1">3.5</td><td align="left" rowspan="1" colspan="1">Transcription factor activity, signal transduction</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CDKN2B</italic></td><td align="left" rowspan="1" colspan="1">6.6</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">Negative regulation of cell cycle</td><td align="left" rowspan="1" colspan="1"><italic>FURIN</italic></td><td align="left" rowspan="1" colspan="1">27.8</td><td align="left" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">Cell&#x02013;cell signaling</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>MLL3</italic></td><td align="left" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">Ubiquitin&#x02013;protein ligase activity, DNA binding</td><td align="left" rowspan="1" colspan="1"><italic>JUNB</italic></td><td align="left" rowspan="1" colspan="1">25.6</td><td align="left" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">Transcription factor activity</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>BRCA2</italic></td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">Nucleic acid binding, DNA repair, regulation of cell cycle</td><td align="left" rowspan="1" colspan="1"><italic>GLI1</italic></td><td align="left" rowspan="1" colspan="1">20.3</td><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">Development, transcription, signal transduction</td></tr></tbody></table><table-wrap-foot><fn><p>The table lists the top 10 genes in each group, sorted by G4P (40 nt search window). The HGNC symbol and values for G4P (both 40 and 100 nt search windows) are shown, along with representative GO terms for each of the genes. The complete list of 55 tumor suppressor genes and 95 proto-oncogenes is available as Supplementary Table 3.</p></fn></table-wrap-foot></table-wrap></sec></back></article>






